hotspot -WSS

hotspot

author：leisure time 2025-09-28 00:53:04 - browse：2753

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Telehealth for opioid use disorder is lifesaving

focus

WSS

How housing is health care on Long Island

FDA approves updated Covid vaccines

Grail is spending more than ever lobbying Congress

Grail is spending more than ever lobbying Congress

Will the IRA bring competition to the biologics market?

When is a doctor not a doctor? Try when patients address women doctors

knowledge

hotspot

hotspot

How to save PrEP access — and even expand it

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Activists slam private health insurers over coverage restrictions

Did the public have the right to know Arthur Ashe had AIDS?

What does generative AI mean for health care? We asked experts

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Wildfire smoke exposes gaps in outdoor worker protections

Russia says it foiled Ukrainian drone attack on Moscow as Kyiv's counteroffensive grinds on

In Memoriam: Notable people who died in 2023

New weight loss drugs vying to be the next Wegovy or Mounjaro

leisure time

Long Covid needs a new name — and a new frame

Inside the fall of star MIT scientist David Sabatini

Popular nasal decongestant doesn't actually relieve congestion

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

PEPFAR is under serious threat — and so is global health

RaDonda Vaught case: a double standard for nurses, physicians

explore

Wikipedia

focus

focus